News

AddToAny

Google+ Facebook Twitter Twitter

Blood markers can predict depression in pregnancy

Signs of inflammation in the blood can reliably predict and identify severe depression in pregnancy, reports a new study.

The team’s analysis established a set of 15 biological markers found in the blood that can predict if pregnant women will experience significant depressive symptoms with 83% accuracy.

The findings could give physicians a much-needed tool to identify women who may be at risk of depression and better tailor their care throughout pregnancy.

Nearly one in five new mothers experience severe depression during or after pregnancy, it is reported, and an estimated 14% have suicidal thoughts.

Inflammation can lead to worsening depressive symptoms, and pregnancy is a major inflammatory event.

Lena Brundin, study co-author, said: “Depression isn’t just something that happens in the brain – its fingerprints are everywhere, including our blood. The ability to predict pregnancy-related depression and its severity will be a gamechanger for protecting the health of mothers and their infants. Our findings are an important leap forward toward this goal.”

The study is among the first of its kind and followed 114 volunteers throughout their pregnancies.

Participants provided blood samples and underwent clinical evaluations for depressive symptoms in each trimester and the postpartum period.

go.nature.com/3H9s4u3

Image Credit | iStock

Related Articles

web_blood-testing_credit_istock-1384651794.png

SPONSORED: The power of automated gel-based ID-cards in routine immunohematology workflows

Immuno-haematology assays are pivotal to the carrying out of blood grouping, antibody screening and transfusions, and represent a critically time-dependent stage in the patient management pathway.

Technician holding a blood sample ready for testing with other human medical samples in the background.-Image credit - Science-Photo-Library-f0243823

Machine learning tool to detect cancer via liquid biopsy

US researchers have developed and tested an innovative machine-learning approach that could one day enable the earlier detection of cancer in patients by using smaller blood draws.

multiple myelomatosis-CREDIT-Science Photo Library-m132099

IBMS research grants

We look at the work of Dr Mosavar Farahani who received an IBMS Research Grant in 2023 to help fund her work on disease progression and skeletal complications in multiple myeloma.

Jaxon Moran and Emily Jones

My Lab: Flow cytometry laboratory

Jaxon Moran and Emily Jones give a guided tour of the Flow Cytometry Laboratory at Newcastle upon Tyne Hospitals NHS Foundation Trust.

Top